Trial Profile
Clinical Trials Insight: 700051436
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 28 Nov 2009
Price :
$35
*
At a glance
- Drugs E 6201 (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 28 Nov 2009 New trial record.